Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Herrmann

Showing results (411-420 of 471) with videos related to

Pageof 48
Sort By:
Frontiers in Aging Neuroscience|May 2, 2018
Theta-Gamma Coupling and Working Memory in Alzheimer's Dementia and Mild Cognitive ImpairmentMichelle S Goodman, Sanjeev Kumar, Reza Zomorrodi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adultsBreno S Diniz, Erica M Vieira, Ana Paula Mendes-Silva, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 14, 2016
Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screeningRichard H Swartz, Mark Bayley, Krista L Lanctôt, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 29, 2020
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With MethylphenidateChristopher H van Dyck, Amy F T Arnsten, Prasad R Padala, et al.
Journal of the American Geriatrics Society|July 19, 2018
Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and MenPaula A Rochon, Andrea Gruneir, Sudeep S Gill, et al.
Stroke|November 23, 2020
Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia PoststrokeMichael Ouk, Che-Yuan Wu, Jessica Colby-Milley, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
Alzheimer'S Research & Therapy|April 28, 2026
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trialDamien Gallagher, Yejin Kang, Nathan Herrmann, et al.
Molecular Neurobiology|June 15, 2017
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-AnalysisCristiano A Köhler, Thiago H Freitas, Brendon Stubbs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Pageof 48

Showing results (411-420 of 471) with videos related to

Sort By:
Pageof 48
Frontiers in Aging Neuroscience|May 2, 2018
Theta-Gamma Coupling and Working Memory in Alzheimer's Dementia and Mild Cognitive ImpairmentMichelle S Goodman, Sanjeev Kumar, Reza Zomorrodi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|April 5, 2021
Mild cognitive impairment and major depressive disorder are associated with molecular senescence abnormalities in older adultsBreno S Diniz, Erica M Vieira, Ana Paula Mendes-Silva, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 14, 2016
Post-stroke depression, obstructive sleep apnea, and cognitive impairment: Rationale for, and barriers to, routine screeningRichard H Swartz, Mark Bayley, Krista L Lanctôt, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|May 29, 2020
Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With MethylphenidateChristopher H van Dyck, Amy F T Arnsten, Prasad R Padala, et al.
Journal of the American Geriatrics Society|July 19, 2018
Initial Cholinesterase Inhibitor Therapy Dose and Serious Events in Older Women and MenPaula A Rochon, Andrea Gruneir, Sudeep S Gill, et al.
Stroke|November 23, 2020
Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia PoststrokeMichael Ouk, Che-Yuan Wu, Jessica Colby-Milley, et al.
JAMA Neurology|September 27, 2021
Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical TrialJacobo Mintzer, Krista L Lanctôt, Roberta W Scherer, et al.
Alzheimer'S Research & Therapy|April 28, 2026
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trialDamien Gallagher, Yejin Kang, Nathan Herrmann, et al.
Molecular Neurobiology|June 15, 2017
Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-AnalysisCristiano A Köhler, Thiago H Freitas, Brendon Stubbs, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2022
Association of functional connectivity of the executive control network or default mode network with cognitive impairment in older adults with remitted major depressive disorder or mild cognitive impairmentNeda Rashidi-Ranjbar, Tarek K Rajji, Colin Hawco, et al.
Pageof 48